Acrivon Therapeutics Inc. Common Stock

NASDAQ ACRV

Data sourced from iex and EODHD
Download Data

Acrivon Therapeutics Inc. Common Stock Cash Flow Statement 2021 - 2024

This table shows the Cash Flow Statement for Acrivon Therapeutics Inc. Common Stock going from 2021 until 2024. The cash flow statement is a financial statement that shows the inflow and outflow of cash and cash equivalents from a company's operating, investing, and financing activities over a specified period. It provides crucial information about a company's ability to generate and manage cash, which is essential for its day-to-day operations, investments, and debt obligations.
Cash Flow Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-03-31
Net Income
M -16 -19 -14 -14 -13 -9 -9 -6 -7 -4 -2 -5
Depreciation and Amortization
M 0 0 0 0 0 0 0 0 0 0 0 0
Non-Cash Items (Other)
M 6 0 0 0 -1 0 0 0 0 0 0 -
Operating Cash Flow
M -17 -12 -10 -9 -11 -9 -7 -6 -8 -4 -2 -4
Capital Expenditures
M -1 -1 0 0 0 0 0 -1 0 0 0 0
Net Acquisitions
M - - - - - - - - - - - -
Other Investing Activities
M - - - - - - - - - - - -
Investing Cash Flow
M - - - - - - - - - - - -
Repayment/Issuance of Debt (Net)
M - - - - - - - - - - - -
Equity Repurchase (Common, Net)
M - - - - - - - - - - - -
Dividends Paid
M - - - - - - - - - - - -
Other Financial Activities
M 0 -1 2 19 9 2 0 -1 0 0 0 0
Financing Cash Flow
M 0 -1 2 19 9 2 0 -1 0 0 0 0
Exchange Rate Adjustment
M - - - - - - - - - - - -
Beginning Cash
M 36 30 38 28 30 32 84 91 100 4 6 -
Ending Cash
M 25 36 30 38 28 30 32 84 91 100 4 -
Stock-Based Compensation
M 3 3 3 3 3 2 0 0 0 0 0 -
Issuance/Purchase of Shares
M - - - - - - - - - - - -
Capital Stock Change
M - - - - - 104 0 - - 100 0 -
Working Capital
M 103 116 135 146 118 121 72 83 83 97 97 -
Free Cash Flow
M -18 -14 -10 -9 -11 -10 -7 -7 -9 -4 -2 -

StockViz Staff

September 16, 2024

Any question? Send us an email